Median Technologies Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Fredrik Brag
Chief executive officer
€737.0k
Total compensation
CEO salary percentage | 54.3% |
CEO tenure | 22.8yrs |
CEO ownership | n/a |
Management average tenure | 4.8yrs |
Board average tenure | 2.1yrs |
Recent management updates
Recent updates
Revenues Tell The Story For Median Technologies SA (EPA:ALMDT) As Its Stock Soars 72%
Aug 30Slammed 28% Median Technologies SA (EPA:ALMDT) Screens Well Here But There Might Be A Catch
Jun 30Investors Give Median Technologies SA (EPA:ALMDT) Shares A 28% Hiding
Mar 14Median Technologies SA (EPA:ALMDT) Looks Just Right With A 26% Price Jump
Jan 03Newsflash: Median Technologies SA (EPA:ALMDT) Analysts Have Been Trimming Their Revenue Forecasts
Jul 14Median Technologies SA (EPA:ALMDT) Might Not Be As Mispriced As It Looks After Plunging 46%
May 05Is Median Technologies (EPA:ALMDT) Using Too Much Debt?
May 07Announcing: Median Technologies (EPA:ALMDT) Stock Increased An Energizing 254% In The Last Year
Dec 28CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -€25m |
Mar 31 2024 | n/a | n/a | -€24m |
Dec 31 2023 | €737k | €400k | -€23m |
Sep 30 2023 | n/a | n/a | -€22m |
Jun 30 2023 | n/a | n/a | -€21m |
Mar 31 2023 | n/a | n/a | -€21m |
Dec 31 2022 | €800k | €400k | -€20m |
Sep 30 2022 | n/a | n/a | -€19m |
Jun 30 2022 | n/a | n/a | -€19m |
Mar 31 2022 | n/a | n/a | -€19m |
Dec 31 2021 | n/a | n/a | -€19m |
Sep 30 2021 | n/a | n/a | -€18m |
Jun 30 2021 | n/a | n/a | -€18m |
Mar 31 2021 | n/a | n/a | -€15m |
Dec 31 2020 | n/a | n/a | -€13m |
Sep 30 2020 | n/a | n/a | -€11m |
Jun 30 2020 | n/a | n/a | -€8m |
Mar 31 2020 | n/a | n/a | -€8m |
Dec 31 2019 | €498k | €400k | -€8m |
Sep 30 2019 | n/a | n/a | -€9m |
Jun 30 2019 | n/a | n/a | -€11m |
Mar 31 2019 | n/a | n/a | -€13m |
Dec 31 2018 | €497k | €400k | -€15m |
Sep 30 2018 | n/a | n/a | -€16m |
Jun 30 2018 | n/a | n/a | -€17m |
Mar 31 2018 | n/a | n/a | -€17m |
Dec 31 2017 | €657k | €400k | -€17m |
Compensation vs Market: Fredrik's total compensation ($USD775.14K) is above average for companies of similar size in the French market ($USD326.61K).
Compensation vs Earnings: Fredrik's compensation has been consistent with company performance over the past year.
CEO
Fredrik Brag
22.8yrs
Tenure
€737,000
Compensation
Mr. Fredrik Brag founded Median Technologies S.A. in 2002 and served as its Chairman and President until April 2019 and serves as its Chief Executive Officer and General Manager. Mr. Brag has been Director...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 22.8yrs | €737.00k | no data | |
Chief Financial Officer | 3.3yrs | no data | no data | |
VP and Head of Investor & Media Relations | no data | no data | no data | |
Head of Corporate & Marketing Communications | no data | no data | no data | |
Chief Human Resources Officer | 1.8yrs | no data | no data | |
Head of Business Development | 12.6yrs | no data | no data | |
Chief Operating Officer of iCRO Business Unit | 6yrs | no data | no data | |
Chief Operating Officer & Chief Commercial Officer – eyonis™ Business Unit | 3.7yrs | no data | no data |
4.8yrs
Average Tenure
Experienced Management: ALMDT's management team is considered experienced (4.8 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 5.6yrs | €737.00k | no data | |
Director | 9yrs | no data | no data | |
Chairman of the Board of Directors | 15.8yrs | €8.00k | no data | |
Director | 4.4yrs | no data | no data | |
Director | 12yrs | €50.00k | no data | |
Member of Clinical Advisory Board for Lung Cancer Screening | 2.1yrs | no data | no data | |
Member of Clinical Advisory Board for Lung Cancer Screening | 2.1yrs | no data | no data | |
Member of Clinical Advisory Board for Lung Cancer Screening | 2.1yrs | no data | no data | |
Member of Clinical Advisory Board for Lung Cancer Screening | 2.1yrs | no data | no data | |
Member of Clinical Advisory Board for Lung Cancer Screening | 2.1yrs | no data | no data | |
Member of Clinical Advisory Board for Lung Cancer Screening | 2.1yrs | no data | no data | |
Member of Clinical Advisory Board for Lung Cancer Screening | 2.1yrs | no data | no data |
2.1yrs
Average Tenure
65.5yo
Average Age
Experienced Board: ALMDT's board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.